Insights from 2025 ASCO® GI Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASCO® GI 2025 Insights: NRG-GI007 Trial - Final Safety Assessment & cCR Rate of CRT With Endoscopically Injected Oncolytic Virus OBP-301 in Medically Inoperable Esophageal Cancer
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Geoffrey Ku
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Geoffrey Ku
Comments 0
Login to view comments.
Click here to Login
